The use of scopolamine to control hypersecrtion in patients under palliative care
DOI:
https://doi.org/10.33448/rsd-v12i10.43258Keywords:
Liquids and secretions; Scopolamine; Palliative care at the end of life.Abstract
The present study aims to carry out a bibliographical review that highlights what the literature provides about the use of Scopolamine Butylbromide to control hypersecretion in patients undergoing palliative care, which is an effective and low-cost alternative. This is an integrative review carried out through Evidence-Based Research with the guiding question: “Has the use of Scopolamine to control hypersecretion been an alternative used to treat patients in palliative care? “. Using the descriptors: “Liquids and Secretions, “Scopolamine” and “Palliative Care at the End of Life” to search for studies. The application of search strategies on the selected platforms resulted in a filtered sample of 09 publications, which made up this review process. The largest number of publications on the topic were found in the Medical Literature Analysis and Retrieval System Online – MEDLINE database through PUBMED, with a total of 5 of the 9 research studies predominantly using English as the language. Through this literature review, it was possible to see that scopolamine can be used to control hypersecretion in patients receiving palliative care. The studies reinforced that in patients in the final stage of life it is common to increase the production of secretions, closely associated with their diagnosis. Non-pharmacological measures can improve this symptom. Scopolamine, as well as other anticholinergic drugs, has been shown to be effective for the treatment of hypersecretion.
References
Alves, R. S. F., Cunha, E. C. N., Santos, G. C., & Melo, M. O. (2019). Cuidados paliativos: alternativa para o cuidado essencial no fim da vida. Psicologia: Ciência e Profissão, 39.
Brock, C., Cooper, S., & Herndon, C. M. (2017). An educational intervention to decrease drug costs related to terminal secretions in a hospice organization. Journal of Pain & Palliative Care Pharmacotherapy, 31(1), 66-70.
Carvalho, R. T. D., & Parsons, H. A. (2012). Manual de cuidados paliativos ANCP. In Manual de cuidados paliativos ANCP (pp. 590-590).
Fernandez-Campos, F., Mallandrich, M., Calpena, A. C., Ayestarán, A., & Lacasa, C. (2013). Stability studies of binary and ternary mixtures containing morphine, midazolam, levomepromazine and hyoscine butylbromide for parenteral administration. Journal of Pharmacy and Pharmacology, 65(3), 379-389.
Ferrari, L. M., & Limberger, J. B. (2021). Medicamentos na prática clínica de pacientes oncológicos em cuidados paliativos. Disciplinarum Scientia| Saúde, 22(1), 315-332.
Freitas, F. A. P. S., Uchôa, I. S., & Magalhães, M. D. A. V. (2020). Importância do Teste de Micronúcleos como Instrumento Preventivo em Saúde Geral e Ambiental. Brazilian Journal of Development, 6(9), 68530-68542.
Ganem, E. M., Salem, I. C., Fukushima, F. B., Nakamura, G., Dias, R., Fontana, A. L., & Leite, N. J. (2005). Eficácia da N-butilescopolamina e dipirona sódica associadas ao cetoprofeno no alívio da dor pós-operatória de pacientes submetidas a duas técnicas diferentes de laqueadura por laparoscopia. Revista Brasileira de Anestesiologia, 55, 397-404.
Kintzel, P. E., Chase, S. L., Thomas, W., Vancamp, D. M., & Clements, E. A. (2009). Anticholinergic medications for managing noisy respirations in adult hospice patients. American Journal of Health-System Pharmacy, 66(5), 458-464.
Lokker, M. E., van Zuylen, L., van der Rijt, C. C., & van der Heide, A. (2014). Prevalence, impact, and treatment of death rattle: a systematic review. Journal of pain and symptom management, 47(1), 105-122.
Mercadante, S., Marinangeli, F., Masedu, F., Valenti, M., Russo, D., Ursini, L., & Aielli, F. (2018). Hyoscine butylbromide for the management of death rattle: sooner rather than later. Journal of pain and symptom management, 56(6), 902-907.
Oliveira Santos, J. K., Magalhães, M. D. A. V., Uchôa, I. S., Freitas, F. A. P. S., & Nascimento, S. T. T. (2022). Comunicação efetiva como forma de inclusão no atendimento à pessoa com deficiência auditiva. Research, Society and Development, 11(13). e351111335212.
Silva, T. S. S., Pedreira, R. B. S., Lima, E. R., dos Santos, L., Reis, T. T., da Rocha, M. P., & da Silva, R. S. (2022). Desafios da equipe multiprofissional em cuidados paliativos no Brasil: revisão integrativa. Research, Society and Development, 11(6), e18511628904-e18511628904.
Uchôa, I. S., Freitas, F. A. P. S., Magalhães, M. D. A. V., Nascimento, S. T. T., & Costa, G. R. (2020). Importância da assistência de enfermagem a pacientes com trauma bucomaxilofacial. Research, Society and Development, 9(11), e1449119580-e1449119580.
Universidade Federal de São Carlos - UFSCar (2014). O uso do cough assist® no controle da hipersecreção respiratória em pacientes em cuidados paliativos – um estudo de viabilidade. Laboratório de Espirometria e Fisioterapia Respiratória, São Carlos. (Dissertação)
Van Esch, H. J., Van Zuylen, L., Geijteman, E. C., Oomen-de Hoop, E., Huisman, B. A., Noordzij-Nooteboom, H. S., & Van Der Rijt, C. C. (2021). Effect of prophylactic subcutaneous scopolamine butylbromide on death rattle in patients at the end of life: the SILENCE randomized clinical trial. Jama, 326(13), 1268-1276.
Vasconcelos, G. B., & Pereira, P. M. (2018). Cuidados paliativos em atenção domiciliar: uma revisão bibliográfica. Revista de Administração em Saúde, 18(70).
Wildiers, H., Dhaenekint, C., Demeulenaere, P., Clement, P. M., Desmet, M., Van Nuffelen, R., & Menten, J. (2009). Atropine, hyoscine butylbromide, or scopolamine are equally effective for the treatment of death rattle in terminal care. Journal of pain and symptom management, 38(1), 124-133.
Yamaki, T., Takahashi, K., Azuhata, O., Itou, D., Yakufujiang, M., Oka, N., & Kobayashi, S. (2022). Longitudinal CT evaluation of transdermal scopolamine for aspiration pneumonia with sialorrhea in severe chronic brain injury: A case series. SAGE Open Medical Case Reports, 10, 2050313X221096227.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Francisco Ariel Paz Santos Freitas; Isabela Soares Uchôa; Maria do Amparo Veloso Magalhães ; Suzanne Tatianne Teixeira Nascimento
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.